Novartis On Payer Contracts, Other Updates From BIO CEO & Investor Conference

Novartis' recent arrangements with Cigna and Aetna tying Entresto reimbursement to outcomes, new Gilead hires and a potential labeling change for Relypsa's Veltassa.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet